Clincosm LogoSign in Get a demo

A Registry of COPD Patients to be Used for Future Studies

Sponsor
Philip Diaz (Other)
Overall Status
Completed
CT.gov ID
NCT00814203
Collaborator
(none)
9
Enrollment
1
Location
24
Duration (Months)
0.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To develop a cohort of COPD participants to assist study staff in determining the most likely candidates for future studies.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To develop a cohort of COPD participants for study staff to determine the most likely candidates for future studies and to develop a repository of blood from subjects with COPD for future studies.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    9 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Ohio State University COPD Registry
    Study Start Date :
    Dec 1, 2008
    Actual Primary Completion Date :
    Dec 1, 2010
    Actual Study Completion Date :
    Dec 1, 2010

    Arms and Interventions

    Arm Intervention/Treatment
    Chronic obstructive lung disease

    those with a condition

    Outcome Measures

    Primary Outcome Measures

    1. This is a registry protocol to determine factors contributing to the development of chronic obstructive lung disease. []

    Secondary Outcome Measures

    1. To develop a repository of blood from subjects with COPD for future studies. These studies may include evaluation of biologic markers of disease severity and progression. []

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Patients who are 18 years of age and older who have been diagnosed with COPD by at least one of the following:

    • clinical history-a documented history of COPD, emphysema, or chronic bronchitis;

    • pulmonary function results (defined as an FEV1/FVC less than 0.7;

    • radiographic results (high-resolution CT findings of emphysema

    Exclusion Criteria:

    • in ability to give informed consent

    • prisoners

    • pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Ohio State University Columbus Ohio United States 43210

    Sponsors and Collaborators

    • Philip Diaz

    Investigators

    • Principal Investigator: Philip Diaz, MD, Ohio State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Philip Diaz, Philip Diaz M.D., Ohio State University
    ClinicalTrials.gov Identifier:
    NCT00814203
    Other Study ID Numbers:
    • 2007H0248
    First Posted:
    Dec 24, 2008
    Last Update Posted:
    Oct 29, 2021
    Last Verified:
    Oct 1, 2021
    Keywords provided by Philip Diaz, Philip Diaz M.D., Ohio State University
    COPD
    Additional relevant MeSH terms:
    Lung Diseases
    Lung Diseases, Obstructive
    Pulmonary Disease, Chronic Obstructive

    Study Results

    No Results Posted as of Oct 29, 2021